Yayın:
Assessment of the Severity of Intermediate Coronary Artery Stenosis Using the Systemic Inflammatory Response Index

dc.contributor.authorAkyel, Serdar
dc.contributor.authorKorkmaz, Ahmet
dc.contributor.authorYıldız, Abdülkadir
dc.date.accessioned2026-01-04T21:40:51Z
dc.date.issued2025-01-13
dc.description.abstractBackground: Fractional Flow Reserve (FFR) is a method that enables the hemodynamic assessment of coronary artery stenosis. The Systemic Inflammatory Response Index (SIRI) is a new marker calculated by multiplying the neutrophil-to-lymphocyte ratio (NLR) with the monocyte count. It is indicative of the presence and severity of coronary artery disease. This study evaluates the relationship between the functional significance of FFR measurements and the SIRI in intermediate coronary stenosis. Methods: A total of 294 patients with 50–70% stenosis in their coronary arteries based on quantitative measurement following angiography who underwent FFR measurement were included in the study before the FFR procedure. Total and differential leukocyte counts and routine biochemical tests were performed. Results: A total of 37% of the patients were found to have a positive FFR, while 63% had a negative FFR. Significant differences were observed in the neutrophil count, monocyte count, Systemic Inflammation Response Index (SIRI), total cholesterol, and amount of adenosine used between the groups (p < 0.05). A SIRI value of 1.16 was 77% sensitive and 55% specific for FFR positivity. Multivariate logistic regression analysis identified the SIRI as an independent predictor of FFR positivity. Conclusions: Our study has demonstrated that high values of the SIRI may serve as a new biomarker for predicting FFR positivity.
dc.description.urihttps://doi.org/10.3390/diagnostics15020162
dc.description.urihttp://dx.doi.org/10.3390/diagnostics15020162
dc.description.urihttps://doaj.org/article/eced844a7e2b488e94ebe612b8d9ca48
dc.identifier.doi10.3390/diagnostics15020162
dc.identifier.eissn2075-4418
dc.identifier.openairedoi_dedup___::df5f984e528a0c62c50d579f90da7139
dc.identifier.orcid0000-0002-0717-8640
dc.identifier.orcid0000-0003-2672-5109
dc.identifier.pubmed39857046
dc.identifier.scopus2-s2.0-85216000928
dc.identifier.startpage162
dc.identifier.urihttps://hdl.handle.net/20.500.12597/42460
dc.identifier.volume15
dc.language.isoeng
dc.publisherMDPI AG
dc.relation.ispartofDiagnostics
dc.rightsOPEN
dc.subjectMedicine (General)
dc.subjectR5-920
dc.subjectfractional flow reserve (FFR)
dc.subjectsystemic inflammatory response index (SIRI)
dc.subjectcoronary artery disease
dc.subjectArticle
dc.titleAssessment of the Severity of Intermediate Coronary Artery Stenosis Using the Systemic Inflammatory Response Index
dc.typeArticle
dspace.entity.typePublication
local.api.response{"authors":[{"fullName":"Serdar Akyel","name":"Serdar","surname":"Akyel","rank":1,"pid":{"id":{"scheme":"orcid","value":"0000-0002-0717-8640"},"provenance":null}},{"fullName":"Ahmet Korkmaz","name":"Ahmet","surname":"Korkmaz","rank":2,"pid":{"id":{"scheme":"orcid_pending","value":"0000-0003-2672-5109"},"provenance":null}},{"fullName":"Abdülkadir Yıldız","name":"Abdülkadir","surname":"Yıldız","rank":3,"pid":null}],"openAccessColor":"gold","publiclyFunded":false,"type":"publication","language":{"code":"eng","label":"English"},"countries":null,"subjects":[{"subject":{"scheme":"keyword","value":"Medicine (General)"},"provenance":null},{"subject":{"scheme":"keyword","value":"R5-920"},"provenance":null},{"subject":{"scheme":"keyword","value":"fractional flow reserve (FFR)"},"provenance":null},{"subject":{"scheme":"keyword","value":"systemic inflammatory response index (SIRI)"},"provenance":null},{"subject":{"scheme":"keyword","value":"coronary artery disease"},"provenance":null},{"subject":{"scheme":"keyword","value":"Article"},"provenance":null}],"mainTitle":"Assessment of the Severity of Intermediate Coronary Artery Stenosis Using the Systemic Inflammatory Response Index","subTitle":null,"descriptions":["<jats:p>Background: Fractional Flow Reserve (FFR) is a method that enables the hemodynamic assessment of coronary artery stenosis. The Systemic Inflammatory Response Index (SIRI) is a new marker calculated by multiplying the neutrophil-to-lymphocyte ratio (NLR) with the monocyte count. It is indicative of the presence and severity of coronary artery disease. This study evaluates the relationship between the functional significance of FFR measurements and the SIRI in intermediate coronary stenosis. Methods: A total of 294 patients with 50–70% stenosis in their coronary arteries based on quantitative measurement following angiography who underwent FFR measurement were included in the study before the FFR procedure. Total and differential leukocyte counts and routine biochemical tests were performed. Results: A total of 37% of the patients were found to have a positive FFR, while 63% had a negative FFR. Significant differences were observed in the neutrophil count, monocyte count, Systemic Inflammation Response Index (SIRI), total cholesterol, and amount of adenosine used between the groups (p &lt; 0.05). A SIRI value of 1.16 was 77% sensitive and 55% specific for FFR positivity. Multivariate logistic regression analysis identified the SIRI as an independent predictor of FFR positivity. Conclusions: Our study has demonstrated that high values of the SIRI may serve as a new biomarker for predicting FFR positivity.</jats:p>"],"publicationDate":"2025-01-13","publisher":"MDPI AG","embargoEndDate":null,"sources":["Crossref","Diagnostics (Basel)","Diagnostics, Vol 15, Iss 2, p 162 (2025)"],"formats":null,"contributors":null,"coverages":null,"bestAccessRight":{"code":"c_abf2","label":"OPEN","scheme":"http://vocabularies.coar-repositories.org/documentation/access_rights/"},"container":{"name":"Diagnostics","issnPrinted":null,"issnOnline":"2075-4418","issnLinking":null,"ep":null,"iss":null,"sp":"162","vol":"15","edition":null,"conferencePlace":null,"conferenceDate":null},"documentationUrls":null,"codeRepositoryUrl":null,"programmingLanguage":null,"contactPeople":null,"contactGroups":null,"tools":null,"size":null,"version":null,"geoLocations":null,"id":"doi_dedup___::df5f984e528a0c62c50d579f90da7139","originalIds":["diagnostics15020162","10.3390/diagnostics15020162","50|doiboost____|df5f984e528a0c62c50d579f90da7139","oai:pubmedcentral.nih.gov:11765139","50|od_______267::e83099e6bf1b8647ee498a7bd8d44729","oai:doaj.org/article:eced844a7e2b488e94ebe612b8d9ca48","50|doajarticles::14cfd1142572937c6e9872a1297b2ecb"],"pids":[{"scheme":"doi","value":"10.3390/diagnostics15020162"}],"dateOfCollection":null,"lastUpdateTimeStamp":null,"indicators":{"citationImpact":{"citationCount":1,"influence":2.6053382e-9,"popularity":3.6538914e-9,"impulse":1,"citationClass":"C5","influenceClass":"C5","impulseClass":"C5","popularityClass":"C5"}},"instances":[{"pids":[{"scheme":"doi","value":"10.3390/diagnostics15020162"}],"license":"CC BY","type":"Article","urls":["https://doi.org/10.3390/diagnostics15020162"],"publicationDate":"2025-01-13","refereed":"peerReviewed"},{"alternateIdentifiers":[{"scheme":"doi","value":"10.3390/diagnostics15020162"}],"license":"CC BY","type":"Other literature type","urls":["http://dx.doi.org/10.3390/diagnostics15020162"],"publicationDate":"2025-01-13","refereed":"nonPeerReviewed"},{"alternateIdentifiers":[{"scheme":"doi","value":"10.3390/diagnostics15020162"}],"type":"Article","urls":["https://doaj.org/article/eced844a7e2b488e94ebe612b8d9ca48"],"publicationDate":"2025-01-01","refereed":"nonPeerReviewed"}],"isGreen":true,"isInDiamondJournal":false}
local.import.sourceOpenAire
local.indexed.atScopus
local.indexed.atPubMed

Dosyalar

Koleksiyonlar